• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Pavmed

Lucid Diagnostics enrolls first patient in study of esophageal DNA test

March 24, 2022 By Sean Whooley

Pavmed (NSDQ:PAVM) subsidiary Lucid Diagnostics announced today that investigators enrolled the first patient in a study of its EsoGuard. Investigators at the Louis Stokes Cleveland Department of Veterans Affairs Medical Center enrolled the patient in a U.S. Department of Defense-funded study of the EsoGuard esophageal DNA test for at-risk patients with gastroesophageal reflux disease (GERD). Lucid Diagnostics […]

Filed Under: Clinical Trials, Diagnostics, Endoscopic, Featured, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: Lucid Diagnostics, Pavmed

PAVmed completes first-in-human implantations of its intraosseous infusion system

March 17, 2022 By Sean Whooley

PAVmed (Nasdaq:PAVM) announced today that it successfully completed the first human implants of its PortIO intraosseous infusion system. New York-based PAVmed designed its PortIO system with an implantable intraosseous vascular access device and insertion kit. Instead of a catheter located in a vein, the system has a short extension from the device inserted by a physician […]

Filed Under: Clinical Trials, Drug Pumps, Drug-Device Combinations, Featured, Implants, Vascular Tagged With: Pavmed

Pavmed appoints Shaun O’Neil as chief operating officer

February 25, 2022 By Danielle Kirsh

Pavmed (NSDQ:PAVM) this week appointed Shaun O’Neil as EVP and COO O’Neil has served as Pavmed’s chief commercial officer and executive VP of business development since joining the company in 2018. Through his new roles, he will be responsible for overseeing diverse corporate operations and commercial activities within Pavmed and its subsidiaries. He will serve […]

Filed Under: Diagnostics, Oncology Tagged With: Pavmed, Personnel Moves

Pavmed acquires CapNostics and its esophageal cell collection device

October 7, 2021 By Sean Whooley

Pavmed (NSDQ:PAVM) announced today that it has agreed to buy CapNostics. The company entered into a definitive membership interest purchase agreement with Martin Von Dyck, the sole member and owner of North Carolina–based CapNostics, according to a news release. CapNostics manufactures the FDA-cleared and CE-marked EsophaCap non-endoscopic esophageal cell collection device used in pre-commercial clinical […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Otolaryngology/Ear, Nose & Throat (ENT), Wall Street Beat Tagged With: CapNostics, Lucid Diagnostics, Pavmed

Pavmed subsidiary Lucid Diagnostics files registration statement for IPO

September 23, 2021 By Sean Whooley

Pavmed (NSDQ:PAVM) subsidiary Lucid Diagnostics announced that Lucid publicly filed a registration statement related to a proposed initial public offering (IPO). The number of shares of common stock and the price range for the offering have not yet been determined, according to a news release. Lucid Diagnostics intends to list its common stock on the Nasdaq market […]

Filed Under: Business/Financial News, Diagnostics, Endoscopic, Featured, Funding Roundup, Initial Public Offering (IPO), Otolaryngology/Ear, Nose & Throat (ENT), Wall Street Beat Tagged With: Lucid Diagnostics, Pavmed

Lucid Diagnostics gains CE mark for esophageal device

May 26, 2021 By Nancy Crotti

Lucid Diagnostics has received the CE mark for its EsoCheck esophageal cell collection device, its parent company announced today. EsoCheck is an FDA-cleared, swallowable balloon capsule catheter that enables a clinician to sample surface cells from the esophagus in a less than five-minute, non-invasive office procedure. Lucid touts EsoCheck as the only such device capable of […]

Filed Under: Diagnostics, Oncology, Regulatory/Compliance Tagged With: CE Mark, Lucid Diagnostics, Pavmed

PAVmed wins CE mark for carpal tunnel device

May 25, 2021 By Nancy Crotti

PAVmed (NSDQ: PAVM) today announced that it has received the CE mark for its CarpX minimally invasive carpal tunnel device. EU-based Notified Body TÜV Rhineland LGA Products GMBH issued CE certificate, effective May 24, 2021, the company noted. CarpX may now be marketed in CE Mark European countries, which include the European Economic Area (the EU, […]

Filed Under: Featured, Regulatory/Compliance, Surgical Tagged With: CE Mark, Pavmed

DTW Podcast: Geoff Martha updates Medtronic’s new course; AJAX CEO Duke Rohlen is funding innovation differently

February 26, 2021 By Tom Salemi

Less than a year into his role as CEO, Geoff Martha and the Medtronic leadership has overseen a significant reorganization of medtech’s largest player. In our closing keynote conversation, Martha says the company is clearing a minor COVID-19 bump and sees open road for the company to continue to grab share from competitors. Martha details […]

Filed Under: Business/Financial News, Device Talks Podcasts, Featured, Special Content Tagged With: Abiomed, ajaxhealth, Asensus Surgical, becton dickinson, DeviceTalks Weekly, Medtronic, Pavmed, Scanwell Health, TransEnterix, Verb Surgical, VIDA FLaSH Acquisitions, Zeus

PavMed to spin off subsidiary Lucid Diagnostics

February 22, 2021 By Sean Whooley

Pavmed (NSDQ:PAVM) announced today that its majority-owned subsidiary Lucid Diagnostics will spin off into a separate public company. In a news release, Pavmed said Lucid Diagnostics intends to spin off if favorable market conditions continue to hold, whether it be through an initial public offering (IPO) or a business combination with a healthcare special purpose acquisition corporation. […]

Filed Under: Business/Financial News, Endoscopic, Featured, Initial Public Offering (IPO), Mergers & Acquisitions, Otolaryngology/Ear, Nose & Throat (ENT), Wall Street Beat Tagged With: Lucid Diagnostics, Pavmed

Pavmed closes $12.4m offering

January 11, 2021 By Sean Whooley

Pavmed (NSDQ:PAVM) announced last week that it closed a registered direct offering of common stock shares worth $12.4 million. New York-based Pavmed’s previously announced offering included 6 million shares of common stock at a price of $2.24 per share, priced at-the-market under Nasdaq rules, according to a news release. The company estimates that the net proceeds […]

Filed Under: Business/Financial News, Diagnostics, Funding Roundup Tagged With: Pavmed

Pavmed raises $7.8M

August 12, 2020 By Sean Whooley

Pavmed (NSDQ:PAVM) filed an SEC Form D to confirm the sale of $7.75 million in an offering of debt and options/warrants to purchase other securities. In selling the $7.75 million, New York-based Pavmed reached its total offering amount in the new notice, which made its first sale on Aug. 5. Pavmed did not intend for the […]

Filed Under: Business/Financial News, Diagnostics, Funding Roundup Tagged With: Pavmed

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 5
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS